Zantac products should not be sold or used, FDA warns, citing cancer danger

Zantac products should not be sold or used, FDA warns, citing cancer danger

Seattle Times

Published

The Food and Drug Administration on Wednesday asked companies to stop selling all forms of the heartburn drug Zantac, after concluding that a potential cancer-causing contaminant can build up in the drug when stored for long periods. The agency also recommended that consumers who use over-the-counter forms of the drug, also known as ranitidine, stop […]

Full Article